Document is current
Any future updates will be listed below
-
Authors
Coassolo, Laetitia
B. Danneskiold-Samsøe, Niels
Nguyen, Quennie https://orcid.org/0009-0003-2604-8256
Wiggenhorn, Amanda https://orcid.org/0000-0001-9413-690X
Zhao, Meng https://orcid.org/0000-0002-5415-8335
Wang, David Cheng-Hao
Toomer, David https://orcid.org/0009-0001-3712-5689
Lone, Jameel
Wei, Yichao
Patel, Aayan
Liparulo, Irene https://orcid.org/0000-0002-2069-0067
Kavi, Deniz
Wat, Lianna W. https://orcid.org/0000-0001-6998-0594
Reghupaty, Saranya Chidambaranathan
Kim, Julie Jae
Asemi, Tina
Bielczyk-Maczynska, Ewa
Li, Veronica L. https://orcid.org/0000-0001-8888-3853
Moya-Garzon, Maria Dolores
Krentz, Nicole A. J.
Stahl, Andreas https://orcid.org/0000-0002-9096-3024
Chou, Danny Hung-Chieh https://orcid.org/0000-0001-9110-614X
Luo, Liqun https://orcid.org/0000-0001-5467-9264
Svensson, Katrin J. https://orcid.org/0000-0001-5376-5128
- License Information
-
More Information
Article History
Received: 15 August 2023
Accepted: 22 January 2025
First Online: 5 March 2025
Competing interests
: K.J.S. and L.C. are named inventors on patents regarding BRP peptides for metabolic disorders. K.J.S. is a co-founder of Merrifield Therapeutics. All other authors declare no competing interests.
